# Ne oldu?

An author correction (erratum) has been officially published for a Nature Medicine article titled "Activating mutations in CSF1R and additional receptor tyrosine kinases in histiocytic neoplasms." The correction addresses errors that were identified in the original publication. This document serves as a formal update to the scientific record, confirming that the previously published findings required modification. The Nature Medicine publication type is listed as "Published Erratum."

# Ayrıntılar

The erratum corrects specific inaccuracies within the original research article. As this is a correction notice rather than new research data, the focus is on the rectification of existing content. The original article investigated the role of activating mutations in CSF1R and other receptor tyrosine kinases in the context of histiocytic neoplasms. The correction ensures that the literature accurately reflects the intended scientific findings, though no new clinical data or patient outcomes are introduced in this erratum notice.

# Neden önemli?

Author corrections are a standard part of the scientific publishing process, maintaining the integrity of the medical literature. For clinicians and researchers relying on the original article for information regarding CSF1R mutations and histiocytic neoplasms, this erratum provides the necessary clarification and correction. It underscores the importance of accuracy in genomic research and the ongoing commitment of peer-reviewed journals like Nature Medicine to correct the record when errors are identified.

# Sırada ne var?

No additional cited references or PubMed-linked articles are associated with this specific erratum notice at this time. The scientific community should refer to the corrected original article for the most current and accurate information regarding CSF1R and receptor tyrosine kinase mutations in histiocytic neoplasms. Ongoing research in this area continues to evolve, and future publications will build upon the corrected foundation.